Clinical trial Recruiting at 2 sites Interventional Ages 15 to 40

Arthrocentesis with ACL Reconstruction for Acute ACL Tears

Official title: Arthrocentesis Study for Perioperative Intervention on Reducing Arthritis and Trauma-related Effects

Run by Ohio State University · NCT07929922 · Data updated 2026-11-12

This trial tests whether draining the knee before and after ACL reconstruction helps reduce inflammation, prevent muscle loss, and speed recovery in people with a recent ACL tear.

Quick facts

Study typeInterventional
Ages15 Years to 40 Years
SexAll
Enrollment54 (estimated)
SponsorOhio State University
Academic / other
Drugs / interventionschemotherapy, prednisone
Locations2 sites (Columbus, Ohio and 1 other locations)
StatusRecruiting
StartedAugust 1, 2026
Main results expectedDecember 31, 2028
Study endsDecember 31, 2029
Registry record updatedNovember 10, 2026
Trial IDNCT07929922 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are ages 15–40 with a recent ACL tear (injury ≤30 days) opting for ACL reconstruction with QT or BPTB grafts.

Probably not a fit

Patients who do not experience significant inflammatory response or who have contraindications to knee aspiration may see little to no benefit.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This randomized trial investigates whether pre- and post-operative knee joint aspiration (arthrocentesis) can lessen toxic blood-related inflammation after ACL injury and surgery. By removing joint fluid around the time of ACL reconstruction, researchers aim to reduce quadriceps atrophy, improve short-term pain, and support faster return of function. The study targets patients aged 15 to 40 with a recent ACL tear who are planned for ACL reconstruction using QT or BPTB grafts. Primary questions focus on inflammatory response and recovery; secondary aims include muscle size, strength at 3 and 6 months, return-to-sport timelines, and 1-year joint wear. The intervention is simple and low-cost, and the trial evaluates safety and potential broader use of post-injury joint drainage.

Why it matters

Potential benefit: If successful, patients may experience less knee inflammation, less muscle wasting, and faster recovery after ACL surgery.

How similar studies have gone: Prior arthrocentesis practices are common, but applying post-operative drainage as a formal trial to alter recovery is an area with limited prior evidence.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

1. Age 15 -40
2. Time from injury to aspiration ≤30 days
3. Patient with a confirmed ACL tear and have elected to have an ACL reconstruction using a quadriceps tendon (QT) or bone-patellar tendon-bone (BPTB) autograft tendon

Exclusion Criteria:

1. Fear of needles or rejection of arthrocentesis
2. Previous knee or ACL surgery on the affected knee
3. Previous cortisone injection in the affected knee within the previous 3 months
4. Concomitant procedures that involve repair or reconstruction of the medial collateral ligament (MCL), posterolateral corner (PLC) or posterior cruciate ligament reconstruction (PCL)
5. Osteoarthritis Kellgren-Lawrence grade ≥3.
6. Cartilage procedures beyond microfracture or chondroplasty
7. Planned osteotomies or meniscus allograft transplantation (MAT)
8. Muscular, vascular or neurological diseases that influence rehabilitation or surgery
9. Current use of prednisone or cytostatic medication
10. Obesity with a BMI ≥45
11. Daily smoking
12. History of illicit drug or alcohol abuse
13. History of prior infection in knee
14. History of chemotherapy treatment
15. History of sickle cell disease
16. Pregnancy during injury or surgery
17. No mastery of the English language

Where it's running

  • Jameson Crane Sports Medicine Institute
    Columbus, Ohio, United States
    Recruiting
  • Ohio State Outpatient Care Dublin
    Dublin, Ohio, United States
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.